FABP5 and posterior cortical atrophy: We demonstrated that SBFI-1143, a member of the truxillic-acid monoester (TAME) family of third-generation FABP5 inhibitors, has a potent suppressive effect on PCa growth compared to the first- and second-generation inhibitors (SBFI-26 and SBFI-103, respectively).